日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer statistics, 2026: Charting a course for a national cancer research agenda

2026年癌症统计数据:为国家癌症研究议程制定路线图

Lara, Primo N Jr; Hershman, Dawn L

POLE Mutation Associated With Microsatellite Instability and High Tumor Mutational Burden Confers Exquisite Sensitivity to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer: A Case Report and Genomic Database Analysis

POLE基因突变与微卫星不稳定性及高肿瘤突变负荷相关,赋予非小细胞肺癌对免疫检查点抑制剂治疗的极高敏感性:病例报告及基因组数据库分析

Lara, Matthew S; Riess, Jonathan W; Kaleka, Guneet; Borowsky, Alexander; McPherson, John D; Godoy, Luis A; Grego, Lorenzo; Lara, Primo N Jr; Mitsiades, Nicholas

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

S1500研究的最终总生存期分析:一项比较舒尼替尼与卡博替尼、克唑替尼和沙伐替尼治疗晚期乳头状肾细胞癌的随机II期研究

Barata, Pedro; Tangen, Catherine; Plets, Melissa; Thompson, Ian M Jr; Narayan, Vivek; George, Daniel J; Heng, Daniel Y C; Shuch, Brian; Stein, Mark; Gulati, Shuchi; Tretiakova, Maria; Tripathi, Abhishek; Bjarnason, Georg A; Humphrey, Peter; Adeniran, Adebowale; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Lara, Primo N Jr; Lerner, Seth P; Balzer-Haas, Naomi; Pal, Sumanta K

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial

转移性激素敏感性前列腺癌患者的骨痛与生存率:SWOG-1216试验的二次分析

Gebrael, Georges; Jo, Yeonjung; Swami, Umang; Plets, Melissa; Hage Chehade, Chadi; Narang, Arshit; Gupta, Shilpa; Myint, Zin W; Sayegh, Nicolas; Tangen, Catherine M; Hussain, Maha; Dorff, Tanya; Lara, Primo N Jr; Lerner, Seth P; Thompson, Ian; Agarwal, Neeraj

Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial

依维莫司辅助治疗非透明细胞肾细胞癌:一项随机临床试验的二次分析

Gulati, Shuchi; Tangen, Catherine; Ryan, Christopher W; Vaishampayan, Ulka N; Shuch, Brian M; Barata, Pedro C; Pruthi, Deepak K; Bergerot, Cristiane D; Tripathi, Abhishek; Lerner, Seth P; Thompson, Ian M Jr; Lara, Primo N Jr; Pal, Sumanta K

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer

循环肿瘤细胞计数与转移性激素敏感性前列腺癌患者的总生存期

Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Bsteh, Daniel; Xu, Tong; Pinski, Jacek K; Ingles, Sue; Triche, Timothy Junius; MacVicar, Gary R; Vaena, Daniel A; Crispino, Anthony W; McConkey, David James; Lara, Primo N Jr; Hussain, Maha H A; Quinn, David I; Dorff, Tanya B; Lerner, Seth Paul; Thompson, Ian Jr; Agarwal, Neeraj

A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)

一项随机、开放标签的 3 期试验,比较帕博利珠单抗联合依帕卡司他与舒尼替尼或帕唑帕尼作为转移性肾细胞癌一线治疗的疗效(KEYNOTE-679/ECHO-302)

Lara, Primo N Jr; Villanueva, Luis; Ibanez, Carolina; Erman, Mustafa; Lee, Jae Lyun; Heinrich, Daniel; Lipatov, Oleg Nikolaevich; Gedye, Craig; Gokmen, Erhan; Acevedo, Alejandro; Semenov, Andrey; Park, Se Hoon; Gafanov, Rustem Airatovich; Kose, Fatih; Jones, Mark; Du, Xiaoqi; Munteanu, Mihaela; Perini, Rodolfo; Choueiri, Toni K; Motzer, Robert J

Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel

骨生物标志物与激素敏感性前列腺癌患者的后续生存率:来自SWOG S1216 III期临床试验的结果,该试验比较了使用或不使用奥特罗内尔的雄激素剥夺疗法。

Lara, Primo N Jr; Mayerson, Edward; Gertz, Erik; Tangen, Catherine; Goldkorn, Amir; van Loan, Marta; Hussain, Maha; Gupta, Shilpa; Zhang, Jingsong; Parikh, Mamta; Twardowski, Przemyslaw; Quinn, David I; LeBlanc, Michael; Vogelzang, Nicholas J; Thompson, Ian; Agarwal, Neeraj

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

依维莫司辅助治疗完全切除的极高危透明细胞肾细胞癌患者:来自3期安慰剂对照SWOG S0931(EVEREST)试验的结果

Lara, Primo N Jr; Tangen, Catherine; Heath, Elisabeth I; Gulati, Shuchi; Stein, Mark N; Meng, Maxwell; Alva, Ajjai Shivaram; Pal, Sumanta K; Puzanov, Igor; Clark, Joseph I; Choueiri, Toni K; Agarwal, Neeraj; Uzzo, Robert; Haas, Naomi B; Synold, Timothy W; Plets, Melissa; Vaishampayan, Ulka N; Shuch, Brian M; Lerner, Seth; Thompson, Ian M Jr; Ryan, Christopher W

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

奥拉帕尼联合或不联合西地尼布治疗转移性去势抵抗性前列腺癌的随机试验:来自美国国家癌症研究所9984研究的结果

Kim, Joseph W; McKay, Rana R; Radke, Marc R; Zhao, Shilin; Taplin, Mary-Ellen; Davis, Nancy B; Monk, Paul; Appleman, Leonard J; Lara, Primo N Jr; Vaishampayan, Ulka N; Zhang, Jingsong; Paul, Asit K; Bubley, Glenn; Van Allen, Eliezer M; Unlu, Serhan; Huang, Ying; Loda, Massimo; Shapiro, Geoffrey I; Glazer, Peter M; LoRusso, Patricia M; Ivy, S Percy; Shyr, Yu; Swisher, Elizabeth M; Petrylak, Daniel P